McDonald Stephen P, Craig Jonathan C
Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Queen Elizabeth Hospital, Adelaide, Australia.
N Engl J Med. 2004 Jun 24;350(26):2654-62. doi: 10.1056/NEJMoa031643.
Although renal-replacement therapy for children with end-stage renal disease has been used for several decades, data on patients' long-term survival are sparse.
We examined the long-term survival of all children and adolescents who were under 20 years of age when renal-replacement therapy commenced (study period, April 1963 through March 2002), using data from the Australia and New Zealand Dialysis and Transplant Registry. Survival was analyzed with the use of Kaplan-Meier methods and age-standardized mortality rates. Risk factors for death were analyzed with the use of Cox regression analysis with time-dependent covariates.
A total of 1634 children and adolescents were followed for a median of 9.7 years. The long-term survival rate among children requiring renal-replacement therapy was 79 percent at 10 years and 66 percent at 20 years. Mortality rates were 30 times as high as for children without end-stage renal disease. Risk factors for death were a young age at the time renal-replacement therapy was initiated (especially for children under 1 year of age, among whom the risk was four times as high as for children 15 to 19 years of age) and treatment with dialysis (which was associated with a risk more than four times as high as for renal transplantation). Overall, a trend toward improved survival was observed over the four decades of the study.
Despite improvement in long-term survival, mortality rates among children requiring renal-replacement therapy remain substantially higher than those among children without end-stage renal disease. Increasing the proportion of children treated with renal transplantation rather than with dialysis can improve survival further.
尽管终末期肾病患儿的肾脏替代治疗已应用数十年,但关于患者长期生存的数据却很稀少。
我们利用澳大利亚和新西兰透析与移植登记处的数据,研究了所有开始肾脏替代治疗时年龄在20岁以下的儿童和青少年的长期生存情况(研究期为1963年4月至2002年3月)。采用Kaplan-Meier方法和年龄标准化死亡率分析生存情况。使用带有时间依存性协变量的Cox回归分析死亡的危险因素。
共对1634名儿童和青少年进行了中位时间为9.7年的随访。需要肾脏替代治疗的儿童10年长期生存率为79%,20年为66%。死亡率是无终末期肾病儿童的30倍。死亡的危险因素包括开始肾脏替代治疗时年龄小(尤其是1岁以下儿童,其风险是15至19岁儿童的4倍)以及接受透析治疗(其风险比肾移植高4倍多)。总体而言,在研究的40年中观察到生存有改善的趋势。
尽管长期生存有所改善,但需要肾脏替代治疗的儿童死亡率仍显著高于无终末期肾病的儿童。增加接受肾移植而非透析治疗的儿童比例可进一步提高生存率。